Why does my GLP-1 provider need to know my exact injection dates?

Escalation decisions, tolerability assessments, and efficacy evaluations all depend on knowing whether you've been at steady state. Steady state for tirzepatide takes ~5 weeks at each dose level. If a provider doesn't know your exact escalation dates, they can't determine whether you've been at steady state long enough to assess the current dose.

Does it matter if I inject on a slightly different day each week?

Minor variation (±1–2 days) has minimal pharmacokinetic impact given the ~5-day half-life of tirzepatide and ~7-day half-life of semaglutide. Consistent weekly timing is easier to track and reduces missed-dose risk. Log the actual injection date regardless of when it was scheduled — accuracy in the record is more important than perfection in timing.

What should I bring to my GLP-1 follow-up appointment?

A complete dose log: every injection date, dose in mg, and any notable side effects. For compounded protocols, also bring the vial reconstitution records (bac water volume, concentration). If you use My Pep Calc, the dose history and half-life chart provide everything your provider needs in one view.

Can I self-adjust my tirzepatide dose without telling my provider?

No. Self-adjusting — escalating early, stepping back without notifying your provider, or changing the prescribed dose — creates a mismatch between your provider's assumed protocol and your actual protocol. This is clinically problematic if a side effect or efficacy question arises, and it removes your provider's ability to accurately assess your response to the prescribed regimen.

Protocol Tracking

Why Your GLP-1 Provider Needs Accurate Dose Logs

What clinical decisions depend on accurate GLP-1 dose history, what a complete escalation log captures, why compounded protocols need more documentation than pen-format drugs, and how to prepare for provider follow-up visits.

Protocol Editor·April 25, 2026

Informational only. Not medical advice. Consult a licensed healthcare provider before starting, changing, or stopping any protocol.

Why your GLP-1 provider needs accurate dose logs

GLP-1 protocols are not "set it and forget it." They require regular clinical review — typically every 4–8 weeks — where the provider assesses tolerability, evaluates progress, and decides whether to escalate, hold, or adjust the dose. Every one of those decisions depends on accurate information about what you've actually taken.

The two most important questions at a GLP-1 follow-up visit:

"Have you been taking it as prescribed?" (compliance)
"When did you escalate and how did you tolerate each step?" (history)

A patient who answers both from memory is less useful to their provider than one who brings a complete dose log. The difference compounds over a multi-month protocol.

What "compliance" actually means in a GLP-1 context

For a weekly subcutaneous GLP-1, compliance means:

Injected on schedule (same day each week, ±1–2 days)
Correct dose at each escalation step
No self-initiated dose changes (escalating early, skipping escalation steps, reducing dose without provider guidance)
Proper reconstitution and storage (for compounded vials)

Partial compliance — injecting but at the wrong dose, or skipping weeks without logging — creates a misleading picture. A provider evaluating "8 weeks on tirzepatide with minimal weight change" needs to know whether that's 8 weeks of steady dosing or 8 weeks with two missed doses and an early escalation.

The dose log as a clinical document

A complete dose log records:

Data point	Why the provider needs it
Injection date and time	Confirms weekly schedule adherence; identifies missed doses
Dose in mg	Confirms you're at the prescribed step, not self-adjusting
Injection site	Identifies site rotation issues that may affect absorption
Side effect notes	Documents tolerability at each dose step over time
Escalation dates	Shows exactly when each step change occurred for correlation with outcomes

Compounded vs. brand-name: why logging matters more for compounded

Brand-name GLP-1 pens (Ozempic, Wegovy, Mounjaro, Zepbound) contain the dose in a pre-set pen format — less calculation required, fewer opportunities for dosing error. Compounded GLP-1 vials require reconstitution, unit calculation, and manual draw — more steps where errors can occur.

For compounded protocols, the log should also capture which vial was used (lot or reconstitution date), the bac water volume added, and the concentration — because if a tolerability issue arises, the provider needs to be able to rule out a reconstitution error versus a true drug response.

Dose log vs. pharmacy refill history

Pharmacy refill history tells your provider when you ordered vials — not when you injected them. A patient who ordered vials on schedule but skipped injections has the same pharmacy history as one who complied fully. Only a dose log captures actual injection dates.

This matters for compounded GLP-1s specifically because there's no pharmacy dispensing data that tracks when the dose was delivered to the body — only when the vial was dispensed. The dose log is the only audit trail for actual protocol execution.

Using My Pep Calc for clinical visit prep

Before a follow-up visit, pull your My Pep Calc dose history for the relevant period. The log shows every injection date, dose, and site — shareable with your provider as a complete record. The half-life chart shows the active concentration curve from your actual logged doses, giving your provider a visual of your pharmacokinetic history, not just a list of dates.

A provider reviewing your half-life chart can see missed doses (visible as concentration dips), early escalations, and whether you've reached steady state at each dose level — context that transforms a 15-minute follow-up from a memory-based conversation into a data-driven clinical review.

Frequently asked questions

Why does my GLP-1 provider need to know my exact injection dates?: Escalation decisions, tolerability assessments, and efficacy evaluations all depend on knowing whether you've been at steady state. Steady state for tirzepatide takes ~5 weeks at each dose level. If a provider doesn't know your exact escalation dates, they can't determine whether you've been at steady state long enough to assess the current dose.
Does it matter if I inject on a slightly different day each week?: Minor variation (±1–2 days) has minimal pharmacokinetic impact given the ~5-day half-life of tirzepatide and ~7-day half-life of semaglutide. Consistent weekly timing is easier to track and reduces missed-dose risk. Log the actual injection date regardless of when it was scheduled — accuracy in the record is more important than perfection in timing.
What should I bring to my GLP-1 follow-up appointment?: A complete dose log: every injection date, dose in mg, and any notable side effects. For compounded protocols, also bring the vial reconstitution records (bac water volume, concentration). If you use My Pep Calc, the dose history and half-life chart provide everything your provider needs in one view.
Can I self-adjust my tirzepatide dose without telling my provider?: No. Self-adjusting — escalating early, stepping back without notifying your provider, or changing the prescribed dose — creates a mismatch between your provider's assumed protocol and your actual protocol. This is clinically problematic if a side effect or efficacy question arises, and it removes your provider's ability to accurately assess your response to the prescribed regimen.

Sources

Blundell J, et al. Medication adherence with GLP-1 receptor agonists: Real-world evidence and clinical implications. Diabetes Obes Metab. 2022.
Eli Lilly. Zepbound (tirzepatide) Prescribing Information. NDA 217806. 2023.

Stop doing this math by hand.

My Pep Calc runs reconstitution, dose tracking, site rotation, and half-life curves for your whole stack — not just one compound.

See the Founders offer →